Market Cap ₹2135 Cr.
Stock P/E -20.1
P/B 1.4
Current Price ₹84
Book Value ₹ 60.8
Face Value 1
52W High ₹104.5
Dividend Yield 1.67%
52W Low ₹ 71.7
Meghmani Organics Ltd went out of commercial enterprise. Meghmani Organics Ltd engages in manufacturing and promoting pigment and agrochemicals merchandise. The corporation operates through three segments: Agro Chemicals, Pigment Business, and Basic Chemicals. The Agro Chemicals section offers technical, intermediates, and formulations of insecticides, fungicides, and herbicides, that are utilized in crop protection, public fitness, termite and insect manage, and veterinary packages. The Pigment Business segment provides phthalocynine green 7, copper phthalocynine blue, alpha blue, and beta blue pigments that are utilized in diverse packages, along with printing inks, plastics, paints, textiles, leather-based, paper, and rubber. The Basic Chemicals section provides caustic chlorine and caustic potash, that are utilized by the agriculture quarter, industry, and immediately by the consumers. It is likewise in the buying and selling of pigment and chemical substances. The organisation mostly operates under the Megastar, Megacyper, Megaban, Synergy, Courage, Correct, and Mega Claim logo names. Meghmani Organics Ltd offers its products to customers thru direct sales groups and vendors/sellers in North America, Europe, Central and Latin America, the Asia Pacific, and the world over. The corporation was previously called Gujarat Industries. Meghmani Organics Ltd is primarily based in Ahmedabad, India.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 640 | 812 | 783 | 646 | 549 | 574 | 426 | 379 | 352 | 410 |
Other Income | 26 | 27 | 38 | 26 | 24 | 9 | 7 | 12 | 10 | 9 |
Total Income | 667 | 838 | 821 | 672 | 573 | 583 | 433 | 391 | 361 | 419 |
Total Expenditure | 562 | 678 | 652 | 567 | 497 | 496 | 448 | 371 | 360 | 408 |
Operating Profit | 105 | 160 | 169 | 104 | 77 | 86 | -15 | 20 | 2 | 11 |
Interest | -3 | 7 | 9 | -3 | 43 | 16 | 4 | 13 | 27 | 2 |
Depreciation | 15 | 17 | 18 | 18 | 18 | 23 | 24 | 23 | 23 | 23 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 19 | 0 | 0 | 0 | 0 |
Profit Before Tax | 93 | 136 | 142 | 89 | 15 | 67 | -43 | -16 | -48 | -14 |
Provision for Tax | 24 | 34 | 33 | 23 | 7 | 13 | -9 | -0 | -10 | 4 |
Profit After Tax | 68 | 102 | 109 | 66 | 8 | 54 | -35 | -15 | -38 | -18 |
Adjustments | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 68 | 102 | 109 | 66 | 8 | 54 | -34 | -15 | -38 | -18 |
Adjusted Earnings Per Share | 2.7 | 4 | 4.3 | 2.6 | 0.3 | 2.1 | -1.4 | -0.6 | -1.5 | -0.7 |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|
Net Sales | 700 | 1637 | 2498 | 2553 | 1567 |
Other Income | 131 | 25 | 98 | 96 | 38 |
Total Income | 830 | 1661 | 2596 | 2649 | 1604 |
Total Expenditure | 595 | 1354 | 2120 | 2212 | 1587 |
Operating Profit | 235 | 307 | 476 | 437 | 18 |
Interest | 18 | 11 | 11 | 66 | 46 |
Depreciation | 22 | 51 | 63 | 77 | 93 |
Exceptional Income / Expenses | 0 | 7 | 6 | 19 | 0 |
Profit Before Tax | 194 | 252 | 409 | 313 | -121 |
Provision for Tax | 45 | 65 | 104 | 75 | -15 |
Profit After Tax | 150 | 186 | 304 | 238 | -106 |
Adjustments | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 150 | 186 | 304 | 238 | -105 |
Adjusted Earnings Per Share | 5.9 | 7.3 | 12 | 9.3 | -4.2 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 2% | 54% | 0% | 0% |
Operating Profit CAGR | -8% | 23% | 0% | 0% |
PAT CAGR | -22% | 17% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 0% | NA% | NA% | NA% |
ROE Average | 15% | 19% | 18% | 18% |
ROCE Average | 17% | 20% | 20% | 20% |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Shareholder's Funds | 986 | 1173 | 1466 | 1669 |
Minority's Interest | 0 | 0 | 0 | 0 |
Borrowings | 56 | 123 | 209 | 402 |
Other Non-Current Liabilities | 63 | 64 | 88 | 98 |
Total Current Liabilities | 552 | 614 | 1035 | 1030 |
Total Liabilities | 1657 | 1974 | 2798 | 3198 |
Fixed Assets | 481 | 634 | 911 | 1166 |
Other Non-Current Assets | 324 | 346 | 451 | 567 |
Total Current Assets | 853 | 995 | 1436 | 1466 |
Total Assets | 1657 | 1974 | 2798 | 3198 |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 8 | 21 | 10 |
Cash Flow from Operating Activities | 22 | 333 | 65 | 204 |
Cash Flow from Investing Activities | -3 | -307 | -133 | -418 |
Cash Flow from Financing Activities | -26 | -14 | 58 | 234 |
Net Cash Inflow / Outflow | -8 | 12 | -10 | 21 |
Closing Cash & Cash Equivalent | 8 | 21 | 10 | 31 |
# | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Earnings Per Share (Rs) | 5.88 | 7.33 | 11.97 | 9.35 |
CEPS(Rs) | 6.76 | 9.33 | 14.43 | 12.38 |
DPS(Rs) | 0 | 1.4 | 1.4 | 1.4 |
Book NAV/Share(Rs) | 38.79 | 46.13 | 57.65 | 65.64 |
Core EBITDA Margin(%) | 14.79 | 17.09 | 15.04 | 13.23 |
EBIT Margin(%) | 30.2 | 15.91 | 16.68 | 14.7 |
Pre Tax Margin(%) | 27.6 | 15.24 | 16.24 | 12.15 |
PAT Margin (%) | 21.26 | 11.28 | 12.1 | 9.22 |
Cash Profit Margin (%) | 24.44 | 14.35 | 14.59 | 12.21 |
ROA(%) | 9.03 | 10.27 | 12.76 | 7.93 |
ROE(%) | 15.16 | 17.27 | 23.07 | 15.16 |
ROCE(%) | 17 | 19.59 | 24.73 | 17.02 |
Receivable days | 239.14 | 96.26 | 69.15 | 75.5 |
Inventory Days | 157.47 | 75.05 | 73.63 | 91.42 |
Payable days | 209.36 | 116.01 | 114.77 | 123.53 |
PER(x) | 0 | 0 | 8.71 | 8.3 |
Price/Book(x) | 0 | 0 | 1.81 | 1.18 |
Dividend Yield(%) | 0 | 0 | 1.34 | 1.8 |
EV/Net Sales(x) | 0.4 | 0.16 | 1.25 | 1.08 |
EV/Core EBITDA(x) | 1.19 | 0.87 | 6.58 | 6.32 |
Net Sales Growth(%) | 0 | 133.96 | 52.66 | 2.17 |
EBIT Growth(%) | 0 | 23.77 | 59.63 | -9.76 |
PAT Growth(%) | 0 | 24.67 | 63.25 | -21.91 |
EPS Growth(%) | 0 | 24.67 | 63.25 | -21.92 |
Debt/Equity(x) | 0.27 | 0.22 | 0.34 | 0.49 |
Current Ratio(x) | 1.55 | 1.62 | 1.39 | 1.42 |
Quick Ratio(x) | 0.99 | 1.01 | 0.77 | 0.79 |
Interest Cover(x) | 11.62 | 23.5 | 38.16 | 5.76 |
Total Debt/Mcap(x) | 0 | 0 | 0.19 | 0.42 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 49.35 | 49.41 | 49.29 | 49.37 | 49.37 | 49.48 | 49.5 | 49.32 | 49.32 | 49.32 |
FII | 1.25 | 1.25 | 1.44 | 1.64 | 1.57 | 1.53 | 1.5 | 1.34 | 1.3 | 1.51 |
DII | 0 | 0.04 | 0.05 | 0.12 | 0.38 | 0.49 | 0.49 | 0.65 | 0.3 | 0.24 |
Public | 49.37 | 49.29 | 49.23 | 48.87 | 48.68 | 48.5 | 48.52 | 48.69 | 49.09 | 48.93 |
Others | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 12.55 | 12.57 | 12.53 | 12.55 | 12.55 | 12.58 | 12.59 | 12.54 | 12.54 | 12.54 |
FII | 0.32 | 0.32 | 0.37 | 0.42 | 0.4 | 0.39 | 0.38 | 0.34 | 0.33 | 0.38 |
DII | 0 | 0.01 | 0.01 | 0.03 | 0.1 | 0.13 | 0.12 | 0.17 | 0.08 | 0.06 |
Public | 12.56 | 12.53 | 12.52 | 12.43 | 12.38 | 12.33 | 12.34 | 12.38 | 12.48 | 12.44 |
Others | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About